Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Early Detection of COPD Patients in GOLD 0 (Smokers) Population (MARKO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01550679
Recruitment Status : Completed
First Posted : March 12, 2012
Last Update Posted : December 29, 2020
Sponsor:
Collaborators:
GlaxoSmithKline
University Hospital Rijeka
Clinical Hospital Center, Split
General Hospital Dubrovnik
Institute for Medical Research and Occupational Health, Zagreb
Osijek University Hospital
Information provided by (Responsible Party):
Davor Plavec, Children's Hospital Srebrnjak

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : April 2020
Actual Study Completion Date : April 2020
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 December 30, 2020
January 21, 2021